CHEK1 and non-small cell lung carcinoma: In addition, miR-195 modulates response of NSCLC cells to microtubule-targeting agents (MTAs) through binding to CHEK1, and CHEK1 silencing synergized with MTAs suppressing the development of NSCLC [19].